Whitehawk Therapeutics, Inc. Common Stock WHWK Q4 2024 Annual earnings
Reported March 18, 2025 · Before market open
EPS estimate-$0.22
Next report
Aug 6, 2026 (in a month)EPS estimate-$0.30
Financials
Q4 2024Valuation & ratios
Versus estimates
Revenue
Q1 2025$7.1M
Q4 2024$7.2M
Diluted EPS
Ask the moment Whitehawk Therapeutics, Inc. Common Stock reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI

Claude
Questions, answered.
- When did Whitehawk Therapeutics, Inc. Common Stock report Q4 2024 earnings?
- Whitehawk Therapeutics, Inc. Common Stock (WHWK) reported Q4 2024 earnings on March 18, 2025 before market open.
- What were Whitehawk Therapeutics, Inc. Common Stock's Q4 2024 revenue and EPS?
- Whitehawk Therapeutics, Inc. Common Stock reported revenue of $7.2M and diluted EPS of $-0.67 for Q4 2024.
- Did Whitehawk Therapeutics, Inc. Common Stock beat estimates in Q4 2024?
- EPS missed the consensus estimate of $-0.22 by $0.45.
- Where can I find Whitehawk Therapeutics, Inc. Common Stock's Q4 2024 SEC filings?
- You can read the 10-K periodic report (0001628280-25-015269) directly on SEC EDGAR. The filing index links above go to sec.gov.